Association of PON1 , APOE and SDF-1 Gene Polymorphisms with Treatment Response to Intravitreal Anti-VEGF Treatment in Patients with Retinal Vein Occlusion.
Antonios RagkousisDimitrios KazantzisIlias GeorgalasPanagiotis TheodossiadisChristos KroupisIrini P ChatziralliPublished in: Seminars in ophthalmology (2023)
L55M SNP may serve as a promising genetic biomarker for predicting response to intravitreal anti-VEGF treatment in patients with macular oedema due to RVO.